ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Bermuda
|
|
77-0481679
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
|
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
Emerging growth company
|
¨
|
|
|
Page
|
Item 1.
|
|
|
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
725,962
|
|
|
$
|
814,092
|
|
Short-term investments
|
923,449
|
|
|
854,268
|
|
||
Accounts receivable, net
|
357,147
|
|
|
335,384
|
|
||
Inventories
|
178,145
|
|
|
171,969
|
|
||
Prepaid expenses and other current assets
|
44,577
|
|
|
58,771
|
|
||
Assets held for sale
|
39,708
|
|
|
45,846
|
|
||
Total current assets
|
2,268,988
|
|
|
2,280,330
|
|
||
Property and equipment, net
|
239,358
|
|
|
243,397
|
|
||
Goodwill and acquired intangible assets, net
|
2,005,912
|
|
|
2,006,984
|
|
||
Other non-current assets
|
121,979
|
|
|
117,939
|
|
||
Total assets
|
$
|
4,636,237
|
|
|
$
|
4,648,650
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
179,017
|
|
|
$
|
143,484
|
|
Accrued liabilities
|
154,315
|
|
|
143,491
|
|
||
Accrued employee compensation
|
132,118
|
|
|
139,647
|
|
||
Deferred income
|
74,064
|
|
|
68,124
|
|
||
Liabilities held for sale
|
746
|
|
|
1,670
|
|
||
Total current liabilities
|
540,260
|
|
|
496,416
|
|
||
Non-current income taxes payable
|
62,720
|
|
|
60,646
|
|
||
Other non-current liabilities
|
71,411
|
|
|
63,937
|
|
||
Total liabilities
|
674,391
|
|
|
620,999
|
|
||
Commitments and contingencies (Note 9)
|
|
|
|
||||
Shareholders’ equity:
|
|
|
|
||||
Common shares, $0.002 par value
|
1,001
|
|
|
1,012
|
|
||
Additional paid-in capital
|
2,876,507
|
|
|
3,016,775
|
|
||
Accumulated other comprehensive income (loss)
|
(164
|
)
|
|
23
|
|
||
Retained earnings
|
1,084,502
|
|
|
1,009,841
|
|
||
Total shareholders’ equity
|
3,961,846
|
|
|
4,027,651
|
|
||
|
|
|
|
||||
Total liabilities and shareholders’ equity
|
$
|
4,636,237
|
|
|
$
|
4,648,650
|
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Net revenue
|
$
|
579,180
|
|
|
$
|
519,383
|
|
Cost of goods sold
|
230,549
|
|
|
244,354
|
|
||
Gross profit
|
348,631
|
|
|
275,029
|
|
||
Operating costs and expenses:
|
|
|
|
||||
Research and development
|
193,027
|
|
|
226,541
|
|
||
Selling, general and administrative
|
55,211
|
|
|
64,163
|
|
||
Restructuring related charges
|
1,505
|
|
|
4,441
|
|
||
Total operating expenses
|
249,743
|
|
|
295,145
|
|
||
Operating income (loss)
|
98,888
|
|
|
(20,116
|
)
|
||
Interest and other income, net
|
3,333
|
|
|
1,488
|
|
||
Income (loss) from continuing operations before income taxes
|
102,221
|
|
|
(18,628
|
)
|
||
Provision (benefit) for income taxes
|
5,251
|
|
|
(5,357
|
)
|
||
Income (loss) from continuing operations
|
96,970
|
|
|
(13,271
|
)
|
||
Income (loss) from discontinued operations, net of tax
|
9,651
|
|
|
(9,408
|
)
|
||
Net income (loss)
|
$
|
106,621
|
|
|
$
|
(22,679
|
)
|
|
|
|
|
||||
Net income (loss) per share - Basic:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
(0.03
|
)
|
Discontinued operations
|
$
|
0.02
|
|
|
$
|
(0.02
|
)
|
Net income (loss) per share - basic
|
$
|
0.21
|
|
|
$
|
(0.04
|
)
|
|
|
|
|
||||
Net income (loss) per share - Diluted:
|
|
|
|
||||
Continuing operations
|
$
|
0.19
|
|
|
$
|
(0.03
|
)
|
Discontinued operations
|
$
|
0.02
|
|
|
$
|
(0.02
|
)
|
Net income (loss) per share - diluted
|
$
|
0.21
|
|
|
$
|
(0.04
|
)
|
|
|
|
|
||||
Weighted average shares:
|
|
|
|
||||
Basic
|
503,790
|
|
|
508,794
|
|
||
Diluted
|
517,592
|
|
|
508,794
|
|
||
|
|
|
|
||||
Cash dividends declared per share
|
$
|
0.06
|
|
|
$
|
0.06
|
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Net income (loss)
|
$
|
106,621
|
|
|
$
|
(22,679
|
)
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
Net change in unrealized gain (loss) on marketable securities
|
(673
|
)
|
|
2,433
|
|
||
Net change in unrealized gain on cash flow hedges
|
1,758
|
|
|
584
|
|
||
Net change in pension liability
|
(1,272
|
)
|
|
—
|
|
||
Other comprehensive income (loss), net of tax
|
(187
|
)
|
|
3,017
|
|
||
Comprehensive income (loss), net of tax
|
$
|
106,434
|
|
|
$
|
(19,662
|
)
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
$
|
106,621
|
|
|
$
|
(22,679
|
)
|
Adjustments to reconcile net income (loss) to net cash provided by (used in)
operating activities:
|
|
|
|
||||
Depreciation and amortization
|
20,742
|
|
|
27,114
|
|
||
Share-based compensation
|
24,017
|
|
|
24,453
|
|
||
Amortization and write-off of acquired intangible assets
|
1,071
|
|
|
2,946
|
|
||
Restructuring related charges
|
(516
|
)
|
|
896
|
|
||
Deferred income taxes and other
|
(11,109
|
)
|
|
(1,115
|
)
|
||
Gain on sale of a business
|
(8,155
|
)
|
|
—
|
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(21,763
|
)
|
|
42,642
|
|
||
Inventories
|
(11,542
|
)
|
|
13,598
|
|
||
Prepaid expenses and other assets
|
6,422
|
|
|
(13,217
|
)
|
||
Accounts payable
|
31,423
|
|
|
19,922
|
|
||
Accrued liabilities
|
448
|
|
|
(22,502
|
)
|
||
Carnegie Mellon University accrued litigation settlement
|
—
|
|
|
(736,000
|
)
|
||
Accrued employee compensation
|
(7,529
|
)
|
|
7,152
|
|
||
Deferred income
|
5,016
|
|
|
(1,234
|
)
|
||
Net cash provided by (used in) operating activities
|
135,146
|
|
|
(658,024
|
)
|
||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of available-for-sale securities
|
(198,416
|
)
|
|
(93,365
|
)
|
||
Sales of available-for-sale securities
|
78,764
|
|
|
272,271
|
|
||
Maturities of available-for-sale securities
|
82,235
|
|
|
97,788
|
|
||
Purchase of time deposits
|
(75,000
|
)
|
|
(50,000
|
)
|
||
Maturities of time deposits
|
75,000
|
|
|
—
|
|
||
Purchases of technology licenses
|
(1,093
|
)
|
|
(4,050
|
)
|
||
Purchases of property and equipment
|
(10,026
|
)
|
|
(11,868
|
)
|
||
Net proceeds from sale of a business
|
22,954
|
|
|
—
|
|
||
Other
|
7,275
|
|
|
—
|
|
||
Net cash provided by (used in) investing activities
|
(18,307
|
)
|
|
210,776
|
|
||
Cash flows from financing activities:
|
|
|
|
||||
Repurchases of common stock
|
(166,293
|
)
|
|
—
|
|
||
Proceeds from employee stock plans
|
19,939
|
|
|
315
|
|
||
Minimum tax withholding paid on behalf of employees for net share settlement
|
(21,809
|
)
|
|
(15,270
|
)
|
||
Dividend payments to shareholders
|
(29,991
|
)
|
|
(30,461
|
)
|
||
Payments on technology license obligations
|
(6,815
|
)
|
|
(5,294
|
)
|
||
Net cash used in financing activities
|
(204,969
|
)
|
|
(50,710
|
)
|
||
Net decrease in cash and cash equivalents
|
(88,130
|
)
|
|
(497,958
|
)
|
||
Cash and cash equivalents at beginning of period
|
814,092
|
|
|
1,278,180
|
|
||
Cash and cash equivalents at end of period
|
$
|
725,962
|
|
|
$
|
780,222
|
|
|
April 29, 2017
|
January 28, 2017
|
||||
Assets held for sale:
|
|
|
||||
Inventory
|
$
|
13,498
|
|
$
|
8,154
|
|
Property and equipment, net
|
1,193
|
|
2,898
|
|
||
Goodwill
|
20,775
|
|
26,532
|
|
||
Acquired intangible assets, net
|
—
|
|
3,799
|
|
||
Other
|
1,490
|
|
1,490
|
|
||
Assets held for sale for discontinued operations
|
36,956
|
|
42,873
|
|
||
Other assets held for sale
|
2,752
|
|
2,973
|
|
||
Total assets of the disposal group classified as held for sale
|
$
|
39,708
|
|
$
|
45,846
|
|
|
|
|
||||
Liabilities held for sale:
|
|
|
||||
Deferred income
|
$
|
746
|
|
$
|
1,670
|
|
|
Three Months Ended
|
|||||
|
April 29, 2017
|
April 30, 2016
|
||||
Net revenue
|
$
|
32,555
|
|
$
|
21,439
|
|
Operating costs and expenses:
|
|
|
||||
Cost of goods sold
|
16,757
|
|
14,856
|
|
||
Research and development
|
12,065
|
|
13,917
|
|
||
Selling, general and administrative
|
1,624
|
|
1,672
|
|
||
Operating costs and expenses
|
30,446
|
|
30,445
|
|
||
Income (loss) from discontinued operations before income taxes
|
2,109
|
|
(9,006
|
)
|
||
Gain from sale of a business
|
8,155
|
|
—
|
|
||
Provision for income taxes
|
613
|
|
402
|
|
||
Income (loss) from discontinued operations, net of tax
|
$
|
9,651
|
|
$
|
(9,408
|
)
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Restructuring related charges:
|
|
|
|
||||
Severance and related costs
|
$
|
2,827
|
|
|
$
|
—
|
|
Facilities and related costs
|
(399
|
)
|
|
3,631
|
|
||
Other exit-related costs
|
380
|
|
|
—
|
|
||
|
2,808
|
|
|
3,631
|
|
||
Release of reserves:
|
|
|
|
||||
Severance
|
(717
|
)
|
|
(86
|
)
|
||
Other exit-related
|
(70
|
)
|
|
—
|
|
||
|
(787
|
)
|
|
(86
|
)
|
||
Impairment and write-off of assets:
|
|
|
|
||||
Technology license
|
174
|
|
|
—
|
|
||
Equipment and other
|
(690
|
)
|
|
896
|
|
||
|
(516
|
)
|
|
896
|
|
||
|
|
|
|
||||
Restructuring related charges
|
$
|
1,505
|
|
|
$
|
4,441
|
|
|
November 2016 Restructuring
|
|
Mobile & Other Prior Restructuring
|
|
|
||||||||||||||||||||||
|
Severance
and Related
Costs
|
|
Facilities
and Related
Costs
|
|
Other
Exit-Related
Costs
|
|
Severance
and Related Costs |
|
Facilities
and Related Costs |
|
Other
Exit-Related Costs |
|
Total
|
||||||||||||||
Balance at January 28, 2017
|
$
|
17,000
|
|
|
$
|
1,763
|
|
|
$
|
4,625
|
|
|
$
|
—
|
|
|
$
|
711
|
|
|
$
|
—
|
|
|
$
|
24,099
|
|
Restructuring charges
|
2,827
|
|
|
(578
|
)
|
|
380
|
|
|
—
|
|
|
179
|
|
|
—
|
|
|
2,808
|
|
|||||||
Net cash payments
|
(3,042
|
)
|
|
(368
|
)
|
|
(56
|
)
|
|
—
|
|
|
(504
|
)
|
|
—
|
|
|
(3,970
|
)
|
|||||||
Release of reserves
|
(717
|
)
|
|
(70
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(787
|
)
|
|||||||
Balance at April 29, 2017
|
$
|
16,068
|
|
|
$
|
747
|
|
|
$
|
4,949
|
|
|
$
|
—
|
|
|
$
|
386
|
|
|
$
|
—
|
|
|
$
|
22,150
|
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
Inventories:
|
|
|
|
||||
Work-in-process
|
$
|
119,035
|
|
|
$
|
110,083
|
|
Finished goods
|
59,110
|
|
|
61,886
|
|
||
Total inventories
|
$
|
178,145
|
|
|
$
|
171,969
|
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
Property and equipment, net:
|
|
|
|
||||
Machinery and equipment
|
$
|
522,366
|
|
|
$
|
578,248
|
|
Buildings and building improvements
|
194,389
|
|
|
194,290
|
|
||
Computer software
|
93,533
|
|
|
99,186
|
|
||
Land
|
53,373
|
|
|
53,373
|
|
||
Leasehold improvements
|
47,852
|
|
|
49,004
|
|
||
Furniture and fixtures
|
23,530
|
|
|
23,903
|
|
||
Construction in progress
|
11,169
|
|
|
11,240
|
|
||
|
946,212
|
|
|
1,009,244
|
|
||
Less: Accumulated depreciation and amortization
|
(706,854
|
)
|
|
(765,847
|
)
|
||
Total property and equipment, net
|
$
|
239,358
|
|
|
$
|
243,397
|
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
Accrued liabilities:
|
|
|
|
||||
Unsettled investment trades
|
$
|
40,299
|
|
|
$
|
15,371
|
|
Restructuring liability
|
21,827
|
|
|
23,150
|
|
||
Accrued royalties
|
16,802
|
|
|
17,349
|
|
||
Technology license obligations
|
15,508
|
|
|
21,905
|
|
||
Accrued rebates
|
14,149
|
|
|
26,095
|
|
||
Accrued legal expense
|
7,155
|
|
|
5,127
|
|
||
Other
|
38,575
|
|
|
34,494
|
|
||
Total accrued liabilities
|
$
|
154,315
|
|
|
$
|
143,491
|
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
Deferred income:
|
|
|
|
||||
Deferred revenue
|
$
|
99,498
|
|
|
$
|
93,148
|
|
Deferred cost of goods sold
|
(25,434
|
)
|
|
(25,024
|
)
|
||
Deferred income
|
$
|
74,064
|
|
|
$
|
68,124
|
|
|
April 29,
2017 |
|
January 28,
2017 |
||||
Other non-current liabilities:
|
|
|
|
||||
Deferred tax liabilities
|
$
|
50,850
|
|
|
$
|
38,777
|
|
Technology license obligations
|
13,612
|
|
|
14,949
|
|
||
Long-term accrued employee compensation
|
5,427
|
|
|
4,075
|
|
||
Other
|
1,522
|
|
|
6,136
|
|
||
Other non-current liabilities
|
$
|
71,411
|
|
|
$
|
63,937
|
|
|
Unrealized Gain
(Loss) on
Marketable
Securities
|
|
Unrealized Gain (Loss) on
Auction Rate
Securities
|
|
Unrealized Gain
(Loss) on Cash
Flow Hedges
|
|
Net Change in Pension Liability
|
|
Total
|
||||||||||
Balance at January 28, 2017
|
$
|
(801
|
)
|
|
$
|
—
|
|
|
$
|
824
|
|
|
$
|
—
|
|
|
$
|
23
|
|
Other comprehensive income (loss) before reclassifications
|
(714
|
)
|
|
—
|
|
|
1,838
|
|
|
(1,272
|
)
|
|
(148
|
)
|
|||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
41
|
|
|
—
|
|
|
(80
|
)
|
|
—
|
|
|
(39
|
)
|
|||||
Other comprehensive income (loss)
|
(673
|
)
|
|
—
|
|
|
1,758
|
|
|
(1,272
|
)
|
|
(187
|
)
|
|||||
Balance at April 29, 2017
|
$
|
(1,474
|
)
|
|
$
|
—
|
|
|
$
|
2,582
|
|
|
$
|
(1,272
|
)
|
|
$
|
(164
|
)
|
|
Unrealized Gain
(Loss) on
Marketable
Securities
|
|
Unrealized Gain (Loss) on
Auction Rate
Securities
|
|
Unrealized Gain
(Loss) on Cash
Flow Hedges
|
|
Total
|
||||||||
Balance at January 30, 2016
|
$
|
(656
|
)
|
|
$
|
—
|
|
|
$
|
(139
|
)
|
|
$
|
(795
|
)
|
Other comprehensive income before reclassifications
|
2,317
|
|
|
—
|
|
|
527
|
|
|
2,844
|
|
||||
Amounts reclassified from accumulated other comprehensive income
|
116
|
|
|
—
|
|
|
57
|
|
|
173
|
|
||||
Other comprehensive income
|
2,433
|
|
|
—
|
|
|
584
|
|
|
3,017
|
|
||||
Balance at April 30, 2016
|
$
|
1,777
|
|
|
$
|
—
|
|
|
$
|
445
|
|
|
$
|
2,222
|
|
|
Three Months Ended
|
||||||
Affected Line Item in the Statements of Operations:
|
April 29,
2017 |
|
April 30,
2016 |
||||
Interest and other income, net:
|
|
|
|
||||
Available-for-sale securities:
|
|
|
|
||||
Marketable securities
|
$
|
(41
|
)
|
|
$
|
(116
|
)
|
Operating costs and expenses:
|
|
|
|
||||
Cash flow hedges:
|
|
|
|
||||
Research and development
|
71
|
|
|
(51
|
)
|
||
Selling, general and administrative
|
9
|
|
|
(6
|
)
|
||
Total
|
$
|
39
|
|
|
$
|
(173
|
)
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Interest and other income, net:
|
|
|
|
||||
Interest income
|
$
|
3,512
|
|
|
$
|
3,442
|
|
Net realized gain on investments
|
25
|
|
|
164
|
|
||
Currency translation loss
|
(90
|
)
|
|
(1,941
|
)
|
||
Other expense
|
(63
|
)
|
|
(59
|
)
|
||
Interest expense
|
(51
|
)
|
|
(118
|
)
|
||
|
$
|
3,333
|
|
|
$
|
1,488
|
|
|
April 29, 2017
|
||||||||||||||
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Available-for-sale:
|
|
|
|
|
|
|
|
||||||||
U.S. government and agency debt
|
$
|
201,084
|
|
|
$
|
92
|
|
|
$
|
(315
|
)
|
|
$
|
200,861
|
|
Foreign government and agency debt
|
9,255
|
|
|
—
|
|
|
(21
|
)
|
|
9,234
|
|
||||
Municipal debt securities
|
24,510
|
|
|
6
|
|
|
(15
|
)
|
|
24,501
|
|
||||
Corporate debt securities
|
439,586
|
|
|
603
|
|
|
(448
|
)
|
|
439,741
|
|
||||
Equity securities
|
65,809
|
|
|
—
|
|
|
(1,381
|
)
|
|
64,428
|
|
||||
Asset backed securities
|
34,679
|
|
|
28
|
|
|
(23
|
)
|
|
34,684
|
|
||||
Held-to-maturity:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
150,000
|
|
|
—
|
|
|
—
|
|
|
150,000
|
|
||||
Total short-term investments
|
924,923
|
|
|
729
|
|
|
(2,203
|
)
|
|
923,449
|
|
||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Available-for-sale:
|
|
|
|
|
|
|
|
||||||||
Auction rate securities
|
4,615
|
|
|
—
|
|
|
—
|
|
|
4,615
|
|
||||
Total long-term investments
|
4,615
|
|
|
—
|
|
|
—
|
|
|
4,615
|
|
||||
Total investments
|
$
|
929,538
|
|
|
$
|
729
|
|
|
$
|
(2,203
|
)
|
|
$
|
928,064
|
|
|
January 28, 2017
|
||||||||||||||
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Estimated
Fair Value
|
||||||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Available-for-sale:
|
|
|
|
|
|
|
|
||||||||
U.S. government and agency debt
|
$
|
185,584
|
|
|
$
|
86
|
|
|
$
|
(283
|
)
|
|
$
|
185,387
|
|
Foreign government and agency debt
|
13,425
|
|
|
—
|
|
|
(50
|
)
|
|
13,375
|
|
||||
Municipal debt securities
|
27,916
|
|
|
4
|
|
|
(49
|
)
|
|
27,871
|
|
||||
Corporate debt securities
|
432,603
|
|
|
281
|
|
|
(776
|
)
|
|
432,108
|
|
||||
Asset backed securities
|
45,541
|
|
|
33
|
|
|
(47
|
)
|
|
45,527
|
|
||||
Held-to-maturity:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
150,000
|
|
|
—
|
|
|
—
|
|
|
150,000
|
|
||||
Total short-term investments
|
855,069
|
|
|
404
|
|
|
(1,205
|
)
|
|
854,268
|
|
||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Available-for-sale:
|
|
|
|
|
|
|
|
||||||||
Auction rate securities
|
4,615
|
|
|
—
|
|
|
—
|
|
|
4,615
|
|
||||
Long-term investments
|
4,615
|
|
|
—
|
|
|
—
|
|
|
4,615
|
|
||||
Total investments
|
$
|
859,684
|
|
|
$
|
404
|
|
|
$
|
(1,205
|
)
|
|
$
|
858,883
|
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Gross realized gains
|
$
|
69
|
|
|
$
|
388
|
|
Gross realized losses
|
(44
|
)
|
|
(224
|
)
|
||
Total net realized gains (losses)
|
$
|
25
|
|
|
$
|
164
|
|
|
April 29, 2017
|
|
January 28, 2017
|
||||||||||||
|
Amortized
Cost
|
|
Estimated
Fair Value
|
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||||||
Due in one year or less
|
$
|
445,416
|
|
|
$
|
445,401
|
|
|
$
|
423,151
|
|
|
$
|
423,058
|
|
Due between one and five years
|
411,498
|
|
|
411,439
|
|
|
423,669
|
|
|
422,995
|
|
||||
Due over five years
|
6,815
|
|
|
6,796
|
|
|
12,864
|
|
|
12,830
|
|
||||
|
$
|
863,729
|
|
|
$
|
863,636
|
|
|
$
|
859,684
|
|
|
$
|
858,883
|
|
|
April 29, 2017
|
||||||||||||||||||||||
|
Less than 12 months
|
|
12 months or more
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Loss
|
|
Fair
Value
|
|
Unrealized
Loss
|
|
Fair
Value
|
|
Unrealized
Loss
|
||||||||||||
U.S. government and agency debt
|
$
|
119,024
|
|
|
$
|
(315
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
119,024
|
|
|
$
|
(315
|
)
|
Foreign government and agency debt
|
9,234
|
|
|
(21
|
)
|
|
—
|
|
|
—
|
|
|
9,234
|
|
|
(21
|
)
|
||||||
Municipal debt securities
|
17,607
|
|
|
(14
|
)
|
|
1,249
|
|
|
(1
|
)
|
|
18,856
|
|
|
(15
|
)
|
||||||
Corporate debt securities
|
146,393
|
|
|
(447
|
)
|
|
829
|
|
|
(1
|
)
|
|
147,222
|
|
|
(448
|
)
|
||||||
Equity securities
|
64,428
|
|
|
(1,381
|
)
|
|
—
|
|
|
—
|
|
|
64,428
|
|
|
(1,381
|
)
|
||||||
Asset backed securities
|
11,864
|
|
|
(23
|
)
|
|
—
|
|
|
—
|
|
|
11,864
|
|
|
(23
|
)
|
||||||
Total securities
|
$
|
368,550
|
|
|
$
|
(2,201
|
)
|
|
$
|
2,078
|
|
|
$
|
(2
|
)
|
|
$
|
370,628
|
|
|
$
|
(2,203
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
January 28, 2017
|
||||||||||||||||||||||
|
Less than 12 months
|
|
12 months or more
|
|
Total
|
||||||||||||||||||
|
Fair
Value
|
|
Unrealized
Loss
|
|
Fair
Value |
|
Unrealized
Loss |
|
Fair
Value |
|
Unrealized
Loss |
||||||||||||
U.S. government and agency debt
|
$
|
94,064
|
|
|
$
|
(283
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
94,064
|
|
|
$
|
(283
|
)
|
Foreign government and agency debt
|
11,875
|
|
|
(48
|
)
|
|
1,499
|
|
|
(2
|
)
|
|
13,374
|
|
|
(50
|
)
|
||||||
Municipal debt securities
|
17,450
|
|
|
(47
|
)
|
|
1,248
|
|
|
(2
|
)
|
|
18,698
|
|
|
(49
|
)
|
||||||
Corporate debt securities
|
199,382
|
|
|
(751
|
)
|
|
16,063
|
|
|
(25
|
)
|
|
215,445
|
|
|
(776
|
)
|
||||||
Asset backed securities
|
16,754
|
|
|
(47
|
)
|
|
—
|
|
|
—
|
|
|
16,754
|
|
|
(47
|
)
|
||||||
Total securities
|
$
|
339,525
|
|
|
$
|
(1,176
|
)
|
|
$
|
18,810
|
|
|
$
|
(29
|
)
|
|
$
|
358,335
|
|
|
$
|
(1,205
|
)
|
|
|
|
Amount of Gains (Losses) in Statement of Operations
|
||||||
|
|
|
Three Months Ended
|
||||||
|
Location of Gains (Losses)
in Statement of Operations
|
|
April 29,
2017 |
|
April 30,
2016 |
||||
Derivatives designated as cash flow hedges:
|
|
|
|
|
|
||||
Forward contracts:
|
Research and development
|
|
$
|
475
|
|
|
$
|
186
|
|
|
Selling, general and administrative
|
|
63
|
|
|
26
|
|
||
|
|
|
$
|
538
|
|
|
$
|
212
|
|
|
Fair Value Measurements at April 29, 2017
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Items measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
7,142
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7,142
|
|
Time deposits
|
—
|
|
|
25,500
|
|
|
—
|
|
|
25,500
|
|
||||
U.S. government and agency debt
|
24,493
|
|
|
—
|
|
|
—
|
|
|
24,493
|
|
||||
Municipal debt securities
|
—
|
|
|
8,740
|
|
|
—
|
|
|
8,740
|
|
||||
Corporate debt securities
|
—
|
|
|
59,517
|
|
|
—
|
|
|
59,517
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
150,000
|
|
|
—
|
|
|
150,000
|
|
||||
U.S. government and agency debt
|
200,861
|
|
|
—
|
|
|
—
|
|
|
200,861
|
|
||||
Foreign government and agency debt
|
—
|
|
|
9,234
|
|
|
—
|
|
|
9,234
|
|
||||
Municipal debt securities
|
—
|
|
|
24,501
|
|
|
—
|
|
|
24,501
|
|
||||
Corporate debt securities
|
—
|
|
|
439,741
|
|
|
—
|
|
|
439,741
|
|
||||
Equity securities
|
64,428
|
|
|
—
|
|
|
—
|
|
|
64,428
|
|
||||
Asset backed securities
|
—
|
|
|
34,684
|
|
|
—
|
|
|
34,684
|
|
||||
Prepaid expenses and other current assets:
|
|
|
|
|
|
|
|
||||||||
Foreign currency forward contracts
|
—
|
|
|
2,376
|
|
|
—
|
|
|
2,376
|
|
||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Auction rate securities
|
—
|
|
|
—
|
|
|
4,615
|
|
|
4,615
|
|
||||
Other non-current assets:
|
|
|
|
|
|
|
|
||||||||
Severance pay fund
|
—
|
|
|
791
|
|
|
—
|
|
|
791
|
|
||||
Total assets
|
$
|
296,924
|
|
|
$
|
755,084
|
|
|
$
|
4,615
|
|
|
$
|
1,056,623
|
|
|
Fair Value Measurements at January 28, 2017
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Items measured at fair value on a recurring basis:
|
|
|
|
|
|
|
|
||||||||
Assets
|
|
|
|
|
|
|
|
||||||||
Cash equivalents:
|
|
|
|
|
|
|
|
||||||||
Money market funds
|
$
|
36,122
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
36,122
|
|
Time deposits
|
—
|
|
|
67,000
|
|
|
—
|
|
|
67,000
|
|
||||
U.S. government and agency debt
|
17,497
|
|
|
—
|
|
|
—
|
|
|
17,497
|
|
||||
Foreign government and agency debt
|
—
|
|
|
1,500
|
|
|
—
|
|
|
1,500
|
|
||||
Corporate debt securities
|
—
|
|
|
31,280
|
|
|
—
|
|
|
31,280
|
|
||||
Municipal debt securities
|
—
|
|
|
8,740
|
|
|
—
|
|
|
8,740
|
|
||||
Short-term investments:
|
|
|
|
|
|
|
|
||||||||
Time deposits
|
—
|
|
|
150,000
|
|
|
—
|
|
|
150,000
|
|
||||
U.S. government and agency debt
|
185,387
|
|
|
—
|
|
|
—
|
|
|
185,387
|
|
||||
Corporate debt securities
|
—
|
|
|
432,108
|
|
|
—
|
|
|
432,108
|
|
||||
Foreign government and agency debt
|
—
|
|
|
13,375
|
|
|
—
|
|
|
13,375
|
|
||||
Municipal debt securities
|
—
|
|
|
27,871
|
|
|
—
|
|
|
27,871
|
|
||||
Asset backed securities
|
—
|
|
|
45,527
|
|
|
—
|
|
|
45,527
|
|
||||
Prepaid expenses and other current assets:
|
|
|
|
|
|
|
|
||||||||
Foreign currency forward contracts
|
—
|
|
|
735
|
|
|
—
|
|
|
735
|
|
||||
Long-term investments:
|
|
|
|
|
|
|
|
||||||||
Auction rate securities
|
—
|
|
|
—
|
|
|
4,615
|
|
|
4,615
|
|
||||
Other non-current assets:
|
|
|
|
|
|
|
|
||||||||
Severance pay fund
|
—
|
|
|
736
|
|
|
—
|
|
|
736
|
|
||||
Total assets
|
$
|
239,006
|
|
|
$
|
778,872
|
|
|
$
|
4,615
|
|
|
$
|
1,022,493
|
|
Liabilities
|
|
|
|
|
|
|
|
||||||||
Accrued liabilities:
|
|
|
|
|
|
|
|
||||||||
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
58
|
|
|
$
|
—
|
|
|
$
|
58
|
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Beginning balance
|
$
|
4,615
|
|
|
$
|
11,296
|
|
Sales and redemptions
|
—
|
|
|
(2,322
|
)
|
||
Ending balance
|
$
|
4,615
|
|
|
$
|
8,974
|
|
|
Three Months Ended
|
||||||
|
April 29,
2017 |
|
April 30,
2016 |
||||
Numerator:
|
|
|
|
||||
Income (loss) from continuing operations
|
$
|
96,970
|
|
|
$
|
(13,271
|
)
|
Income (loss) from discontinued operations
|
9,651
|
|
|
(9,408
|
)
|
||
Net income (loss)
|
$
|
106,621
|
|
|
$
|
(22,679
|
)
|
Denominator:
|
|
|
|
||||
Weighted average shares — basic
|
503,790
|
|
|
508,794
|
|
||
Effect of dilutive securities:
|
|
|
|
||||
Share-based awards
|
13,802
|
|
|
—
|
|
||
Weighted average shares — diluted
|
517,592
|
|
|
508,794
|
|
||
Income (loss) from continuing operations per share:
|
|
|
|
||||
Basic
|
$
|
0.19
|
|
|
$
|
(0.03
|
)
|
Diluted
|
$
|
0.19
|
|
|
$
|
(0.03
|
)
|
Income (loss) from discontinued operations per share:
|
|
|
|
||||
Basic
|
$
|
0.02
|
|
|
$
|
(0.02
|
)
|
Diluted
|
$
|
0.02
|
|
|
$
|
(0.02
|
)
|
Net income (loss) per share:
|
|
|
|
||||
Basic
|
$
|
0.21
|
|
|
$
|
(0.04
|
)
|
Diluted
|
$
|
0.21
|
|
|
$
|
(0.04
|
)
|
|
Three Months Ended
|
||||
|
April 29,
2017 |
|
April 30,
2016 |
||
Weighted average shares outstanding:
|
|
|
|
||
Share-based awards
|
9,166
|
|
|
42,955
|
|
•
|
our ability to successfully restructure our operations within our anticipated timeframe announced in November 2016 and with our anticipated amounts of costs and savings;
|
•
|
our dependence upon the hard disk drive market, which is highly cyclical and intensely competitive;
|
•
|
the outcome of pending or future litigation and legal proceedings;
|
•
|
our dependence on a small number of customers;
|
•
|
severe financial hardship or bankruptcy of one or more of our major customers;
|
•
|
our ability and the ability of our customers to successfully compete in the markets in which we serve;
|
•
|
our reliance on independent foundries and subcontractors for the manufacture, assembly and testing of our products;
|
•
|
our ability and our customers’ ability to develop new and enhanced products and the adoption of those products in the market;
|
•
|
decreases in our gross margin and results of operations in the future due to a number of factors;
|
•
|
our ability to estimate customer demand and future sales accurately;
|
•
|
our ability to scale our operations in response to changes in demand for existing or new products and services;
|
•
|
the impact of international conflict and continued economic volatility in either domestic or foreign markets;
|
•
|
the effects of transitioning to smaller geometry process technologies;
|
•
|
the risks associated with manufacturing and selling a majority of our products and our customers’ products outside of the United States;
|
•
|
risks associated with acquisition and consolidation activity in the semiconductor industry;
|
•
|
the impact of any change in our application of the United States federal income tax laws and the loss of any beneficial tax treatment that we currently enjoy;
|
•
|
the effects of any potential acquisitions or investments;
|
•
|
our ability to protect our intellectual property;
|
•
|
the impact and costs associated with changes in international financial and regulatory conditions; and
|
•
|
our maintenance of an effective system of internal controls.
|
|
Three Months Ended
|
||||
|
April 29, 2017
|
|
April 30, 2016
|
||
End Customer:
|
|
|
|
||
Western Digital*
|
21.5
|
%
|
|
20.4
|
%
|
Toshiba
|
13.1
|
%
|
|
11.9
|
%
|
Seagate
|
10.3
|
%
|
|
9.9
|
%
|
Samsung
|
**
|
|
|
10.3
|
%
|
Distributor:
|
|
|
|
||
Wintech
|
10.0
|
%
|
|
10.0
|
%
|
*
|
The percentage of net revenue reported for Western Digital in the three months ended April 29, 2017 and April 20, 2016 includes net revenue of HGST and Sandisk which became subsidiaries of Western Digital in late fiscal 2016.
|
**
|
Less than 10% of net revenue
|
|
Three Months Ended
|
||||
|
April 29, 2017
|
|
April 30, 2016
|
||
Net revenue
|
100.0
|
%
|
|
100.0
|
%
|
Cost of goods sold
|
39.8
|
|
|
47.0
|
|
Gross profit
|
60.2
|
|
|
53.0
|
|
Operating costs and expenses:
|
|
|
|
||
Research and development
|
33.3
|
|
|
43.6
|
|
Selling, general and administrative
|
9.5
|
|
|
12.4
|
|
Restructuring related charges
|
0.3
|
|
|
0.9
|
|
Total operating costs and expenses
|
43.1
|
|
|
56.9
|
|
Operating income (loss) from continuing operations
|
17.1
|
|
|
(3.9
|
)
|
Interest and other income, net
|
0.5
|
|
|
0.3
|
|
Income (loss) from continuing operations before income taxes
|
17.6
|
|
|
(3.6
|
)
|
Provision (benefit) for income taxes
|
0.9
|
|
|
(1.0
|
)
|
Income (loss) from continuing operations
|
16.7
|
%
|
|
(2.6
|
)%
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
%
Change
|
|||||
|
(in thousands, except percentage)
|
|||||||||
Net revenue
|
$
|
579,180
|
|
|
$
|
519,383
|
|
|
11.5
|
%
|
|
Three Months Ended
|
||||
|
April 29, 2017
|
|
April 30, 2016
|
||
|
(in thousands, except percentage)
|
||||
Cost of goods sold
|
230,549
|
|
|
244,354
|
|
|
|
|
|
||
Gross profit
|
348,631
|
|
|
275,029
|
|
% of net revenue
|
60.2
|
%
|
|
53.0
|
%
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
%
Change
|
|||||
|
(in thousands, except percentage)
|
|||||||||
Research and development
|
$
|
193,027
|
|
|
$
|
226,541
|
|
|
(14.8
|
)%
|
% of net revenue
|
33.3
|
%
|
|
43.6
|
%
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
%
Change
|
|||||
|
(in thousands, except percentage)
|
|||||||||
Selling, general and administrative
|
$
|
55,211
|
|
|
$
|
64,163
|
|
|
(14.0
|
)%
|
% of net revenue
|
9.5
|
%
|
|
12.4
|
%
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
% Change
|
|||||
|
(in thousands)
|
|||||||||
Restructuring related charges
|
$
|
1,505
|
|
|
$
|
4,441
|
|
|
(66.1
|
)%
|
% of net revenue
|
0.3
|
%
|
|
0.9
|
%
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
%
Change
|
|||||
|
(in thousands, except percentage)
|
|||||||||
Interest and other income, net
|
$
|
3,333
|
|
|
$
|
1,488
|
|
|
124.0
|
%
|
% of net revenue
|
0.5
|
%
|
|
0.3
|
%
|
|
|
|
Three Months Ended
|
|
|
|||||||
|
April 29, 2017
|
|
April 30, 2016
|
|
%
Change
|
|||||
|
(in thousands, except percentage)
|
|||||||||
Provision (benefit) for income taxes
|
$
|
5,251
|
|
|
$
|
(5,357
|
)
|
|
(198.0
|
)%
|
•
|
changes in general economic and political conditions and specific conditions in the end markets we address, including the continuing volatility in the technology sector and semiconductor industry;
|
•
|
the highly competitive nature of the end markets we serve, particularly within the semiconductor industry;
|
•
|
our dependence on a few customers for a significant portion of our revenue;
|
•
|
severe financial hardship or bankruptcy of one or more of our major customers;
|
•
|
our ability to maintain a competitive cost structure for our manufacturing and assembly and test processes and our reliance on third parties to produce our products;
|
•
|
our ability to successfully restructure our operations within our anticipated timeframe announced in November 2016 and with our anticipated savings;
|
•
|
the effects of any potential acquisitions, divestitures or significant investments;
|
•
|
any current and future litigation that could result in substantial costs and a diversion of management’s attention and resources that are needed to successfully maintain and grow our business;
|
•
|
cancellations, rescheduling or deferrals of significant customer orders or shipments, as well as the ability of our customers to manage inventory;
|
•
|
gain or loss of a design win or key customer;
|
•
|
seasonality in sales of consumer devices in which our products are incorporated;
|
•
|
failure to qualify our products or our suppliers’ manufacturing lines;
|
•
|
our ability to develop and introduce new and enhanced products in a timely and effective manner, as well as our ability to anticipate and adapt to changes in technology;
|
•
|
failure to protect our intellectual property;
|
•
|
impact of a significant natural disaster, including earthquakes, floods and tsunamis, particularly in certain regions in which we operate or own buildings, such as Santa Clara, California and where our third party suppliers operate, such as Taiwan and elsewhere in the Pacific Rim; and
|
•
|
our ability to attract and retain a highly skilled workforce, especially managerial, engineering, sales and marketing personnel.
|
•
|
a significant portion of our sales are made on a purchase order basis, which allows our customers to cancel, change or delay product purchase commitments with relatively short notice to us;
|
•
|
customers may purchase integrated circuits from our competitors;
|
•
|
customers may discontinue sales or lose market share in the markets for which they purchase our products;
|
•
|
customers may develop their own solutions or acquire fully developed solutions from third-parties;
|
•
|
customers may be subject to severe business disruptions, including, but not limited to, those driven by financial instability; or
|
•
|
customers may consolidate (for example, Western Digital acquired SanDisk in 2017, and Toshiba Corporation has announced an intent to sell a portion of its semiconductor business), which could lead to changing demand for our products, replacement of our products by the merged entity with those of our competitors and cancellation of orders.
|
•
|
diversion of management attention from running our existing business;
|
•
|
increased expenses, including but not limited to legal, administrative and compensation expenses related to newly hired or terminated employees;
|
•
|
increased costs to integrate or, in the case of a divestiture, separate the technology, personnel, customer base and business practices of the acquired or divested business or assets;
|
•
|
potential exposure to material liabilities not discovered in the due diligence process;
|
•
|
potential adverse effects on reported operating results due to possible write-down of goodwill and other intangible assets associated with acquisitions;
|
•
|
potential damage to customer relationships or loss of synergies in the case of divestitures; and
|
•
|
unavailability of acquisition financing on reasonable terms or at all.
|
•
|
failure to obtain regulatory or other approvals;
|
•
|
IP disputes or other litigation; or
|
•
|
difficulties obtaining financing for the transaction.
|
•
|
loss of or delay in market acceptance of our products;
|
•
|
material recall and replacement costs;
|
•
|
delay in revenue recognition or loss of revenue;
|
•
|
writing down the inventory of defective products;
|
•
|
the diversion of the attention of our engineering personnel from product development efforts;
|
•
|
our having to defend against litigation related to defective products or related property damage or personal injury; and
|
•
|
damage to our reputation in the industry that could adversely affect our relationships with our customers.
|
•
|
political, social and economic instability, including wars, terrorism, political unrest, boycotts, curtailment of trade and other business restrictions;
|
•
|
volatile global economic conditions, including downturns in which some competitors may become more aggressive in their pricing practices, which would adversely impact our gross margin;
|
•
|
compliance with domestic and foreign export and import regulations, including pending changes thereto, and difficulties in obtaining and complying with domestic and foreign export, import and other governmental approvals, permits and licenses;
|
•
|
local laws and practices that favor local companies, including business practices in which we are prohibited from engaging by the Foreign Corrupt Practices Act and other anti-corruption laws and regulations;
|
•
|
difficulties in staffing and managing foreign operations;
|
•
|
natural disasters, including earthquakes, tsunamis and floods;
|
•
|
trade restrictions, higher tariffs, or changes in cross border taxation, particularly in light of the prospect of changes in U.S. international trade policies following the recent U.S. presidential election;
|
•
|
transportation delays;
|
•
|
difficulties of managing distributors;
|
•
|
less effective protection of intellectual property than is afforded to us in the United States or other developed countries;
|
•
|
inadequate local infrastructure; and
|
•
|
exposure to local banking, currency control and other financial-related risks.
|
•
|
stop selling, offering for sale, making, having made or exporting products or using technology that contains the allegedly infringing intellectual property;
|
•
|
limit or restrict the type of work that employees involved in such litigation may perform for us;
|
•
|
pay substantial damages and/or license fees and/or royalties to the party claiming infringement or other license violations that could adversely impact our liquidity or operating results;
|
•
|
attempt to obtain or renew licenses to the relevant intellectual property, which licenses may not be available on reasonable terms or at all; and
|
•
|
attempt to redesign those products that contain the allegedly infringing intellectual property.
|
•
|
the possibility of environmental contamination and the costs associated with remediating any environmental problems;
|
•
|
adverse changes in the value of these properties due to interest rate changes, changes in the neighborhood in which the property is located, or other factors;
|
•
|
the possible need for structural improvements in order to comply with zoning, seismic and other legal or regulatory requirements;
|
•
|
the potential disruption of our business and operations arising from or connected with a relocation due to moving to or renovating the facility;
|
•
|
increased cash commitments for improvements to the buildings or the property, or both;
|
•
|
increased operating expenses for the buildings or the property, or both;
|
•
|
possible disputes with tenants or other third parties related to the buildings or the property, or both;
|
•
|
failure to achieve expected cost savings due to extended non-occupancy of a vacated property intended to be leased; and
|
•
|
the risk of financial loss in excess of amounts covered by insurance, or uninsured risks, such as the loss caused by damage to the buildings as a result of earthquakes, floods and/or other natural disasters.
|
Period (1)
|
Total Number of
Shares Purchased
|
|
Average Price
Paid per Share
|
|
Total Number of Shares
Purchased as Part of
Publicly Announced Plans or
Programs
|
|
Approximate Dollar Value of
Shares that May Yet Be
Purchased Under the Plans or
Programs (2)
|
||||||
January 29 – February 25, 2017
|
545,722
|
|
|
$
|
15.58
|
|
|
545,722
|
|
|
$
|
875,527
|
|
February 26 – March 25, 2017
|
5,649,594
|
|
|
$
|
15.98
|
|
|
5,649,594
|
|
|
$
|
785,268
|
|
March 26 – April 29, 2017
|
4,337,939
|
|
|
$
|
15.22
|
|
|
4,337,939
|
|
|
$
|
719,238
|
|
Total
|
10,533,255
|
|
|
$
|
15.65
|
|
|
10,533,255
|
|
|
$
|
719,238
|
|
(1)
|
The monthly periods presented above for the three months ended
April 29, 2017
, are based on our fiscal accounting periods which follow a quarterly 4-4-5 week fiscal accounting period.
|
(2)
|
On November 17, 2016, the Company announced that its Board of Directors authorized a $1 billion share repurchase plan. The newly authorized stock repurchase program replaces in its entirety the prior $3.25 billion stock repurchase program, which had approximately $115 million of repurchase authority remaining as of November 17, 2016. We intend to effect share repurchases in accordance with the conditions of Rule 10b-18 under the Exchange Act, but may also make repurchases in the open market outside of Rule 10b-18 or in privately negotiated transactions. The share repurchase program will be subject to market conditions and other factors and does not obligate us to repurchase any dollar amount or number of our common shares and the repurchase program may be extended, modified, suspended or discontinued at any time.
|
Exhibit No.
|
|
Item
|
|
Form
|
|
File Number
|
|
Incorporated by
Reference from
Exhibit Number
|
|
Filed with SEC
|
3.1
|
|
Memorandum of Association of Marvell Technology Group Ltd.
|
|
S-1
|
|
333-33086
|
|
3.1
|
|
3/23/2000
|
3.2
|
|
Fourth Amended and Restated Bye-Laws of Marvell Technology Group Ltd.
|
|
8-K
|
|
000-30877
|
|
3.1
|
|
11/10/2016
|
3.3
|
|
Memorandum of Increase of Share Capital of Marvell Technology Group Ltd.
|
|
8-K
|
|
000-30877
|
|
3.1
|
|
7/6/2006
|
10.1#
|
|
Offer Letter between the Company and Neil Kim
|
|
|
|
|
|
|
|
Filed herewith
|
10.2#
|
|
Separation Agreement between the Company and Maya Strelar-Migotti
|
|
|
|
|
|
|
|
Filed herewith
|
10.3#
|
|
Separation and Form of Consulting Agreement between the Company and Dr. Pantelis Alexopoulos
|
|
|
|
|
|
|
|
Filed herewith
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Principal Executive Officer
|
|
|
|
|
|
|
|
Filed herewith
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Principal Financial Officer
|
|
|
|
|
|
|
|
Filed herewith
|
32.1*
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Principal Executive Officer
|
|
|
|
|
|
|
|
Filed herewith
|
32.2*
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Principal Financial Officer
|
|
|
|
|
|
|
|
Filed herewith
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
Filed herewith
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
Filed herewith
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
Filed herewith
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Document
|
|
|
|
|
|
|
|
Filed herewith
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
Filed herewith
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
Filed herewith
|
#
|
Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.
|
*
|
The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.
|
|
MARVELL TECHNOLOGY GROUP LTD.
|
|
|
||
Date: June 5, 2017
|
By:
|
/s/ JEAN HU
|
|
|
Jean Hu
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
•
|
Time Based RSU Award (TB-RSU)
- a restricted stock unit award of common shares of Marvell equal to: $600,000 / Share Price (as defined below), rounded down to the nearest whole share.
|
•
|
Performance Based RSU Award based on Total Shareholder Return (TSR-RSU)
- a restricted stock unit award of common shares of Marvell equal to: $450,000 / Share Price (as defined below), rounded down to the nearest whole share (such amount is the “target” number).
|
•
|
Performance Based RSU Award based on Operating Performance Metrics (OP-RSU)
- a restricted stock unit award of common shares of Marvell equal to: $450,000 / Share Price (as defined below), rounded down to the nearest whole share (such amount is the “target” number)
|
•
|
Hire-On Time Based RSU Award (HOTB-RSU)
- a restricted stock unit award of common shares of Marvell equal to: $700,000 / Share Price (as defined below), rounded down to the nearest whole share.
|
•
|
Hire-On Performance Based RSU Award based on Total Shareholder Return (HOTSR-RSU)
- a hire-on restricted stock unit award of common shares of Marvell equal to: $530,000 / Share Price (as defined below) rounded down to the nearest whole share (such amount is the “target” number).
|
•
|
Hire-On Performance Based RSU Award based on Operating Performance Metrics (HOOP-RSU)
- a restricted stock unit award of common shares of Marvell equal to: $530,000 / Share Price (as defined below) rounded down to the nearest whole share (such amount is the “target” number)
|
•
|
Cash Signing Bonus
. You will also be paid a one-time cash bonus of $500,000 US Dollars (USD), subject to applicable withholding taxes, which will be paid within 30 days of your commencement of employment. Cash bonus, though paid in advance, is earned over the year of your employment, and is paid in consideration of your provision of services over the year period. If you voluntarily terminate your employment with the Company within the first year of your date of hire, you will be required to repay the Company a pro-rated amount of the bonus based on the number of days remaining in the 365 day period.
|
•
|
A valid driver’s license and social security card, or
|
•
|
A current passport
|
•
|
Successful completion of a routine background investigation and reference checks;
|
•
|
The Company’s receipt from you of a signed New Hire Employee Agreement, which contains the Company's Confidential Information and Invention Assignment Agreement and Arbitration Agreement; and
|
•
|
Completion of visa, license requirements, and government restricted party screening requirements, if applicable.
|
/s/ Neil Kim
|
|
|
|
April 24, 2017
|
Neil Kim
|
|
Date Signed
|
|
Start Date
|
1.
|
SEPARATION.
You will remain an employee of the Company through your resignation date of January 7, 2017, unless your employment terminates earlier in accordance with Section 12 below (the last day of employment, whether January 7, 2017 or earlier, shall be referred to as the “Separation Date”). Effective October 14, 2016, you are released from your day-to-day responsibilities and no longer report to work, but you agree to be available as needed through the Separation Date to provide consultation and transition services to the Company. You agree to execute the Termination Certificate attached to this Agreement as Exhibit A on the Separation Date. You agree to execute the Bridge Release attached to this Agreement as Exhibit C no earlier than the Separation Date and no later than 7 days following your Separation Date.
|
2.
|
FINAL PAYMENTS.
On the Separation Date, the Company will pay you your final paycheck, which will include all wages due and owing through the Separation Date, as well as payment for any accrued, unused flexible time off (“FTO”), i.e., vacation pay, earned through the Separation Date, subject to standard deductions and withholdings. You are entitled to, and will be paid, all wages due and owing, as well as payment for accrued, unused FTO, upon the termination of your employment, regardless of whether you sign this Agreement.
|
3.
|
SEPARATION BENEFITS.
The Company shall provide you with the following special separation benefits (collectively, “Separation Benefits”):
|
a.
|
You will continue to receive your base salary through the Separation Date (“Salary Continuation”);
|
b.
|
The Company will pay you a separation payment in the amount of $400,000, which is the equivalent of one year of base salary, and a lump sum cash payment of $300,000, which is the equivalent for your target annual bonus for fiscal year 2017 (collectively, the “Separation Payment”). The Separation Payment is payable within 30 business days after your Separation Date and will be subject to applicable tax withholding;
|
c.
|
The Company will pay you a lump sum cash payment of $24,270, which is the equivalent of the value of twelve (12) months’ premium for continuation of coverage under the Marvell Semiconductor Medical, Dental and Vision Plans for you and your dependents (“COBRA Lump Sum”). You are not required to elect continuation of coverage to receive this benefit. The COBRA Lump Sum is payable within 30 business days after your Separation Date and will subject to applicable tax withholding.
|
d.
|
No portion of the sign-on bonus paid pursuant to your offer letter dated June 24, 2015 shall be repayable.
|
4.
|
EQUITY.
You were previously granted certain options to acquire shares of Common Stock of the Company’s parent corporation, Marvell Technology Group Ltd., a Bermuda corporation (the “Parent”), as well as Restricted Stock Units (“RSU’s”) and performance shares (the stock option, performance shares and RSU grants are referred to collectively as the “Grant”). A detailed description of your Grant, reflecting vesting information as of January 7, 2017, is set forth in the Closing Statement attached to this Agreement as Exhibit B. As of the Separation Date, you shall cease to vest in any shares of Common Stock and RSU’s under the Grant. On or after the Separation Date, you will receive an updated Closing Statement reflecting vesting information though the Separation Date. As of the Separation Date, all unvested shares under the Grant will be cancelled
|
5.
|
ESPP CONTRIBUTIONS.
On the Separation Date, you will be refunded all contributions made by you (if any) during the current enrollment period to the Company 2000 Employee Stock Purchase Plan (“ESPP”). Your ESPP reimbursement will be included in the final paycheck. You agree that as of the Separation Date, you will no longer be eligible to participate in the ESPP.
|
6.
|
HEALTH INSURANCE.
If you are currently participating in the Company's group health insurance plans, these plans will cease as of the last day of the month in which your employment terminates. Thereafter, you are entitled to continue to participate in these programs through COBRA provided that you properly elect to continue your health insurance benefits under COBRA and pay the COBRA premiums. You will be provided with a separate notice of your COBRA rights.
|
7.
|
EXPENSE REIMBURSEMENTS.
You agree to submit any final business expenses for reimbursement as soon as possible, but no later than October 31, 2016. Any outstanding expense reimbursements will be made to you within 30 days of this Agreement. You covenant and agree not to incur any further expenses or out of pocket charges on behalf of the Company after the date of this letter.
|
8.
|
OTHER COMPENSATION AND BENEFITS.
Except as expressly provided for in this Agreement, you will not receive (nor are you entitled to receive) any other salary, bonuses, vacation or other paid leave, stock options, RSUs, or any other compensation or benefits of any kind. You are not eligible for, and you will not receive, any further bonus or other incentive compensation. You acknowledge that, except as expressly set forth in this Agreement, you are not entitled to receive any severance or separation benefits. You understand and agree that the payments and benefits to be provided to you pursuant to this Agreement substantially exceed the benefits to which you would be entitled in the absence of this Agreement and no other compensation is owed to you except as provided herein.
|
9.
|
GENERAL RELEASE.
You and your representatives completely release the Company, its affiliated, related, sibling, parent and subsidiary companies, and their present and former directors, officers, employees and insurers (collectively, the “Released Parties”) from all claims of any kind, known and unknown, that you had in the past or now have against the Released Parties through the date you sign this Agreement (except for claims arising out of this Agreement). Without limitation, this full waiver and release includes all claims for compensation of any kind, and all claims arising from your employment with the Company, the termination of your employment, and/or the events leading up to the termination of your employment, and the terms of the Grant or its cancellation, whether based on contract, tort, statute, local ordinance, regulation or any comparable law in any jurisdiction (collectively, the “Released Claims”). By way of example and not in limitation, the Released Claims shall include any claims arising under section 806 of the Sarbanes-Oxley Act of 2002 (“Civil Whistle Blower Provisions”), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Older Workers Benefit and Protection Act, the Family and Medical Leave Act, the California Labor Code, the California Family Rights Act and the California Fair Employment and Housing Act, as well as any claims asserting wrongful termination, discrimination, retaliation, harassment, breach of contract, breach of the covenant of good faith and fair dealing, all claims related to the return or recovery of any personal property allegedly remaining with or left at the Company, negligent or intentional infliction of emotional distress, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, and defamation, provided, however, that you are not releasing any claims to challenge the validity of this release under the Age Discrimination in Employment Act, any claims that arise after you sign this Agreement, or any claims that you cannot waive by operation of law. Additionally, nothing in this Agreement precludes you from filing a charge or complaint with or participating in any investigation or proceeding before any federal or state agency, including the Equal Employment Opportunity Commission (“EEOC”). However, while you may file a charge and participate in any proceeding conducted by a state or federal agency, by signing this Agreement, you waive your right to bring a lawsuit against the Released Parties and waive your right to individual monetary recovery in any action or lawsuit initiated by the EEOC or any federal or state agency.
|
10.
|
SECTION 1542 WAIVER.
You understand and further agree that because this release specifically covers all known and unknown or unanticipated claims, rights, demands, actions, obligations, liabilities, and causes of action of every kind and character that would otherwise come within the scope of the released claims as described in Sections 9 and 17, you waive your rights under California Civil Code section 1542, which states as follows:
|
11.
|
COVENANT NOT TO SUE.
You also agree not to initiate or cause to be initiated against any of the Released Parties any lawsuit or proceedings of any kind concerning any events or claims that predate your signing this Agreement, subject to the limitations set forth in Section 9.
|
12.
|
EARLIER RESIGNATION
. You may commence other employment or consulting work prior to the Separation date, provided you give us notice of such employment and, if it is with a direct competitor, you agree to resign your employment with the Company.
|
13.
|
LIMITATIONS ON AUTHORITY.
You acknowledge and agree that you are no longer authorized to incur any expenses, obligations, or liabilities on behalf of the Company, or to represent or purport to represent the Company in any manner with any third party.
|
14.
|
COMPANY PROPERTY AND PROPRIETARY INFORMATION.
You hereby represent and warrant to the Company that you have returned to the Company all Company documents (and all copies thereof) and other Company property which you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including cellular telephones and laptop computers), credit cards, entry cards, and keys; and, any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof) (“Company Property”). You also acknowledge that the terms of the Confidential Information and Invention Assignment Agreement you signed as a condition of your employment with the Company shall remain in effect after your employment with the Company ends.
|
15.
|
NONDISPARAGEMENT.
You understand and agree that as a condition of the benefits the Company has agreed to give you pursuant to this Agreement, you will not at any time disparage the Company, make any false or derogatory statements to any person or entity, including any media outlet, in any manner likely to be harmful to the Company, or to the personal or business reputation of the Company, its directors, shareholders, agents, and employees. Nothing in this section shall prohibit you from providing truthful information in response to a subpoena or other legal process.
|
16.
|
CONFIDENTIALITY.
You understand and agree to hold the provisions of this Agreement in strictest confidence as a condition of the benefits, and you agree not to publicize or disclose the terms of this Agreement in any manner whatsoever; provided, however, that you may disclose this Agreement to: (a) your spouse or domestic partner; (b) your attorney, accountant, or financial advisor; or (c) insofar as disclosure may be necessary to enforce its terms or as required by law.
|
17.
|
VOLUNTARY AND KNOWING RELEASE.
You expressly understand and acknowledge that among the various rights and claims being waived and released by you are any and all claims arising under the Age Discrimination in Employment Act of 1967, as amended, the California Fair Employment and Housing Act, and any federal, state, or local discrimination, employment or other laws. By your signature below, you acknowledge each of the following:
|
18.
|
EFFECTIVE DATE.
For all purposes, this Agreement shall become effective on the eighth day after you execute the Agreement so long as you have not revoked the Agreement in accordance with Section 17(f) (“Effective Date”).
|
19.
|
ENTIRE AGREEMENT.
This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with respect to the subject matter hereof. The Agreement is executed without reliance upon any promise, warranty or representation, written or oral, by any party or any representative of any party other than those expressly contained herein and it supersedes any other such promises, warranties or representations. You acknowledge that you have carefully read this Agreement, have been afforded the opportunity to be advised of its meaning and consequences by an attorney, and signed the same of your own free will. This Agreement may not be amended or modified except in writing signed by both you and the Company’s Chief Legal Officer. Each party will bear its own costs or fees incurred in connection with the making of this Agreement.
|
20.
|
APPLICABLE LAW.
This Agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California. Any action brought to enforce this Agreement, and any action arising out of, in connection with, or relating to this Agreement, shall be subject to the exclusive jurisdiction of the state and federal courts located in the Northern District of California. Both parties waive the right to a jury trial in any such action, and each party shall bear the costs and fees it incurs in any such action.
|
21.
|
SEVERABILITY.
If a court of competent jurisdiction determines that any term or provision of this Agreement is invalid or unenforceable, in whole or in part, then the remaining terms and the provisions hereof shall be unimpaired. Such court will have the authority to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision that most accurately represents the parties’ intention with respect to the invalid or unenforceable term or provision.
|
22.
|
SUCCESSORS AND ASSIGNS.
This Agreement shall bind the heirs, personal representatives, successors, assigns, executors, and administrators of each party, and inures to the benefit of each party, its or his/her heirs, successors and assigns. However, because of the unique and personal nature of your duties under this Agreement, you agree that you may not delegate the performance of your duties under this Agreement.
|
Date:
|
|
|
|
|
|
|
Maya Strelar-Migotti
|
1.
|
GENERAL RELEASE.
You and your representatives completely release the Company, its affiliated, related, sibling, parent and subsidiary companies, and their present and former directors, officers, employees and insurers (collectively, the “Released Parties”) from all claims of any kind, known and unknown, that you had in the past or now have against the Released Parties through the date you sign this Bridge Release (except for claims arising out of the Separation Agreement and this Bridge Release). Without limitation, this full waiver and release includes all claims for compensation of any kind, and all claims arising from your employment with the Company, the termination of your employment, and/or the events leading up to the termination of your employment, and the terms of the Grant or its cancellation, whether based on contract, tort, statute, local ordinance, regulation or any comparable law in any jurisdiction (collectively, the “Released Claims”). By way of example and not in limitation, the Released Claims shall include any claims arising under Section 806 of the Sarbanes-Oxley Act of 2002 (“Civil Whistle Blower Provisions”), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Older Workers Benefit and Protection Act, the Family and Medical Leave Act, the California Labor Code, the California Family Rights Act, and the California Fair Employment and Housing Act, as well as any claims asserting wrongful termination, discrimination, retaliation, harassment, breach of contract, breach of the covenant of good faith and fair dealing, all claims related to the return or recovery of any personal property allegedly remaining with or left at the Company, negligent or intentional infliction of emotional distress, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, and defamation, provided, however, that you are not releasing any claims to challenge the validity of this release under the Age Discrimination in Employment Act, any claims brought before the EDD, any claims that arise after you sign this Bridge Release, or any claims that you cannot waive by operation of law. Not withstanding the above, this Agreement is not waiving (a) claims relating to the validity of this Agreement; (b) claims which are not legally waiveable; (c) claims for coverage under any D&O or other similar insurance policy or (d) claims for indemnification under any statute or agreement with the Company.
|
2.
|
SECTION 1542 WAIVER.
You further agree that because this release specifically covers known and unknown claims, you waive your rights under Section 1542 of the California Civil Code, which states as follows:
|
3.
|
VOLUNTARY AND KNOWING RELEASE.
By your signature below, you acknowledge each of the following:
|
4.
|
ENTIRE AGREEMENT.
This Bridge Release and the Separation Agreement, constitute the complete, final and exclusive embodiment of the entire agreement between you and the Company with respect to the subject matter hereof. The Bridge Release is executed without reliance upon any promise, warranty or representation, written or oral, by any party or any
|
5.
|
APPLICABLE LAW.
This Bridge Release shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California. Any action brought to enforce this Bridge Release, and any action arising out of, in connection with, or relating to this Bridge Release, shall be subject to the exclusive jurisdiction of the state and federal courts located in the Northern District of California. Both parties waive the right to a jury trial in any such action, and each party shall bear the costs and fees it incurs in any such action.
|
1.
|
SEPARATION.
You will remain an employee of the Company through your resignation date of April 30, 2017 (referred to as the “Separation Date”). You agree to execute the Termination Certificate attached to this Agreement as Exhibit A on the Separation Date. You agree to execute the Bridge Release attached to this Agreement as Exhibit C no earlier than the Separation Date and no later than 7 days following your Separation Date.
|
2.
|
FINAL PAYMENTS.
On the Separation Date, the Company will pay you your final paycheck, which will include all wages due and owing through the Separation Date, as well as payment for any accrued, unused flexible time off (“FTO”), i.e., vacation pay, earned through the Separation Date, subject to standard deductions and withholdings. You are entitled to, and will be paid, all wages due and owing, as well as payment for accrued, unused FTO, upon the termination of your employment, regardless of whether you sign this Agreement.
|
3.
|
SEPARATION BENEFITS.
Provided that you continue to perform your duties through the Separation Date and are not terminated for Cause (as defined below) prior to the Separation Date, the Company shall provide you with the following special separation benefits (collectively, “Separation Benefits”):
|
a.
|
You will continue to receive your base salary through the Separation Date (“Salary Continuation”);
|
b.
|
The Company will pay you a separation payment in the amount of $400,000, which is the equivalent of one year of base salary, and a lump sum cash payment of $300,000, which is the equivalent for your target annual bonus for fiscal year 2018, and a lump sum cash payment of $240,000, which is in lieu of your incentive compensation bonus for fiscal year 2017 (collectively, the “Separation Payment”). The Separation Payment is payable within 30 business days after your Separation Date and will be subject to applicable tax withholding;
|
c.
|
The Company will pay you a lump sum cash payment of $22,700, which is the equivalent of the value of twelve (12) months’ premium for continuation of coverage under the Marvell Semiconductor Medical, Dental and Vision Plans for you and your dependents (“COBRA Lump Sum”). You are not required to elect continuation of coverage to receive this benefit. The COBRA Lump Sum is payable within 30 business days after your Separation Date and will subject to applicable tax withholding.
|
d.
|
For purposes of this Section 3, “Cause” means : (A) an act of material dishonesty in connection with your job responsibilities; (B) conviction of, or plea of nolo contendere to, a felony or any crime involving fraud, embezzlement or moral turpitude; (C) gross misconduct; (D) willful unauthorized use or disclosure of any proprietary information or trade secrets of the Company or Marvell Technology Group Ltd. (“Marvell”); (E) willful breach of any obligations under any written agreement with the Company or Marvell that is not cured within 10 days after your receipt of written notice from the Company specifying the breach; (F) willful refusal to cooperate in good faith with a governmental or internal investigation of the Company, Marvell or their directors, officers or employees, if the Company or Marvell has requested your cooperation.
|
e.
|
Should Marvell terminate Alexopoulos’ employment for cause, and/or refuses to pay Alexopoulos any of the payments set forth above in paragraph 3, Alexopoulos may seek to enforce his rights under this agreement and to obtain the above payments. In any such action the prevailing party is entitled to reasonable attorney’s fees and costs.
|
4.
|
CONSULTING SERVICES.
The Company desires to utilize your experience and knowledge following the Separation Date by establishing a consulting relationship with you pursuant to a Consulting Agreement between you and MSI in the form attached hereto as Exhibit D (the “Consulting Agreement”).
|
5.
|
EQUITY.
You were previously granted certain options to acquire shares of Common Stock of the Company’s parent corporation, Marvell Technology Group Ltd., a Bermuda corporation (the “Parent”), as well as Restricted Stock Units (“RSU’s”) and performance shares (the stock option, performance shares and RSU grants are referred to collectively as the “Grant”). A detailed description of your Grant, reflecting vesting information as of January 23, 2017, is set forth in the Closing Statement attached to this Agreement as Exhibit B. As of the Separation Date, you shall cease to vest in any shares of Common Stock, options and RSU’s under the Grant. On or after the Separation Date, you will receive an updated Closing Statement reflecting vesting information though the Separation Date. As of the Separation Date, all unvested shares under the Grant will be cancelled.
|
6.
|
ESPP CONTRIBUTIONS.
On the Separation Date, you will be refunded all contributions made by you (if any) during the current enrollment period to the Company 2000 Employee Stock Purchase Plan (“ESPP”). Your ESPP reimbursement will be included in the final paycheck. You agree that as of the Separation Date, you will no longer be eligible to participate in the ESPP.
|
7.
|
HEALTH INSURANCE.
If you are currently participating in the Company's group health insurance plans, these plans will cease as of the last day of the month in which your employment terminates. Thereafter, you are entitled to continue to participate in these programs through COBRA provided that you properly elect to continue your health insurance benefits under COBRA and pay the COBRA premiums. You will be provided with a separate notice of your COBRA rights
|
8.
|
EXPENSE REIMBURSEMENTS.
You agree to submit any final business expenses for reimbursement as soon as possible, but no later than May 30, 2017. Any outstanding expense reimbursements will be made to you within 30 days of this Agreement. You covenant and agree not to incur any further expenses or out of pocket charges on behalf of the Company after the date of this letter.
|
9.
|
OTHER COMPENSATION AND BENEFITS.
Except as expressly provided for in this Agreement, you will not receive (nor are you entitled to receive) any other salary, bonuses, vacation or other paid leave, stock options, RSUs, or any other compensation or benefits of any kind. You are not eligible for, and you will not receive, any further bonus or other incentive compensation. You acknowledge that, except as expressly set forth in this Agreement, you are not entitled to receive any severance or separation benefits. You understand and agree that the payments and benefits to be provided to you pursuant to this Agreement substantially exceed the benefits to which you would be entitled in the absence of this Agreement and no other compensation is owed to you except as provided herein.
|
10.
|
GENERAL RELEASE.
You and your representatives completely release the Company, its affiliated, related, sibling, parent and subsidiary companies, and their present and former directors, officers, employees and insurers (collectively, the “Released Parties”) from all claims of any kind, known and unknown, that you had in the past or now have against the Released Parties through the date you sign this Agreement (except for claims arising out of this Agreement). Without limitation, this full waiver and release includes all claims for compensation of any kind, and all claims arising from your employment with the Company, the termination of your employment, and/or the events leading up to the termination of your employment, and the terms of the Grant or its cancellation, whether based on contract, tort, statute, local ordinance, regulation or any comparable law in any jurisdiction (collectively, the “Released Claims”). By way of example and not in limitation, the Released Claims shall include any claims arising under section 806 of the Sarbanes-Oxley Act of 2002 (“Civil Whistle Blower Provisions”), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Older Workers Benefit and Protection Act, the Family and Medical Leave Act, the California Labor Code, the California Family Rights Act and the California Fair Employment and Housing Act, as well as any claims asserting wrongful termination, discrimination, retaliation, harassment, breach of contract, breach of the covenant of good faith and fair dealing, all claims related to the return or recovery of any personal property allegedly remaining with or left at the Company, negligent or intentional infliction of emotional distress, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, and defamation, provided, however, that you are not releasing any claims to challenge the validity of this release under the Age Discrimination in Employment Act, any claims that arise after you sign this Agreement, or any claims that you cannot waive by operation of law. Additionally, nothing in this Agreement precludes you from filing a charge or complaint with or participating in any investigation or proceeding before any federal or state agency, including the Equal Employment Opportunity Commission (“EEOC”). However, while you may file a charge and participate in any proceeding conducted by a state or federal agency, by signing this Agreement, you waive your right to bring a lawsuit against the Released Parties and waive your right to individual monetary recovery in any action or lawsuit initiated by the EEOC or any federal or state agency.
|
11.
|
SECTION 1542 WAIVER.
You understand and further agree that because this release specifically covers all known and unknown or unanticipated claims, rights, demands, actions, obligations, liabilities, and causes of action of every kind and character that would otherwise come within the scope of the released claims as described in Sections 9 and 17, you waive your rights under California Civil Code section 1542, which states as follows:
|
12.
|
COVENANT NOT TO SUE.
You also agree not to initiate or cause to be initiated against any of the Released Parties any lawsuit or proceedings of any kind concerning any events or claims that predate your signing this Agreement, subject to the limitations set forth in Section 9.
|
13.
|
LIMITATIONS ON AUTHORITY.
You acknowledge and agree that you are no longer authorized to incur any expenses, obligations, or liabilities on behalf of the Company, or to enter into any contracts or arrangements on behalf of the Company in any manner with any third party.
|
14.
|
COMPANY PROPERTY AND PROPRIETARY INFORMATION.
You hereby represent and warrant to the Company that you have returned to the Company all Company documents (and all copies thereof) and other Company property which you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including cellular telephones and laptop computers), credit cards, entry cards, and keys; and, any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof) (“Company Property”). You also acknowledge that the terms of the Confidential Information and Invention Assignment Agreement you signed as a condition of your employment with the Company shall remain in effect after your employment with the Company ends.
|
15.
|
NONDISPARAGEMENT.
You understand and agree that as a condition of the benefits the Company has agreed to give you pursuant to this Agreement, you will not at any time disparage the Company, make any false or derogatory statements to any person or entity, including any media outlet, in any manner likely to be harmful to the Company, or to the personal or business reputation of the Company, its directors, shareholders, agents, and employees. Nothing in this section shall prohibit you from providing truthful information in response to a subpoena or other legal process.
|
16.
|
CONFIDENTIALITY.
You understand and agree to hold the provisions of this Agreement in strictest confidence as a condition of the benefits, and you agree not to publicize or disclose the terms of this Agreement in any manner whatsoever; provided, however, that you may disclose this Agreement to: (a) your spouse or domestic partner; (b) your attorney, accountant, or financial advisor; or (c) insofar as disclosure may be necessary to enforce its terms or as required by law.
|
17.
|
VOLUNTARY AND KNOWING RELEASE.
You expressly understand and acknowledge that among the various rights and claims being waived and released by you are any and all claims arising under the Age Discrimination in Employment Act of 1967, as amended, the California Fair Employment and Housing Act, and any federal, state, or local discrimination, employment or other laws. By your signature below, you acknowledge each of the following:
|
18.
|
EFFECTIVE DATE.
For all purposes, this Agreement shall become effective on the eighth day after you execute the Agreement so long as you have not revoked the Agreement in accordance with Section 17(f) (“Effective Date”).
|
19.
|
ENTIRE AGREEMENT.
This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with respect to the subject matter hereof. The Agreement is executed without reliance upon any promise, warranty or representation, written or oral, by any party or any representative of any party other than those expressly contained herein and it supersedes any other such promises, warranties or representations. You acknowledge that you have carefully read this Agreement, have been afforded the opportunity to be advised of its meaning and consequences by an attorney, and signed the same of your own free will. This Agreement may not be amended or modified except in writing signed by both you and the Company’s Chief Legal Officer. Each party will bear its own costs or fees incurred in connection with the making of this Agreement.
|
20.
|
APPLICABLE LAW.
This Agreement shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California. Any action brought to enforce this Agreement, and any action arising out of, in connection with, or relating to this Agreement, shall be subject to the exclusive jurisdiction of the state and federal courts located in the Northern District of California. Both parties waive the right to a jury trial in any such action, and each party shall bear the costs and fees it incurs in any such action.
|
21.
|
SEVERABILITY.
If a court of competent jurisdiction determines that any term or provision of this Agreement is invalid or unenforceable, in whole or in part, then the remaining terms and the provisions hereof shall be unimpaired. Such court will have the authority to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision that most accurately represents the parties’ intention with respect to the invalid or unenforceable term or provision.
|
22.
|
SUCCESSORS AND ASSIGNS.
This Agreement shall bind the heirs, personal representatives, successors, assigns, executors, and administrators of each party, and inures to the benefit of each party, its or his/her heirs, successors and assigns. However, because of the unique and personal nature of your duties under this Agreement, you agree that you may not delegate the performance of your duties under this Agreement.
|
Date:
|
|
|
|
|
|
|
Pantelis Alexopoulos
|
1.
|
GENERAL RELEASE.
You and your representatives completely release the Company, its affiliated, related, sibling, parent and subsidiary companies, and their present and former directors, officers, employees and insurers (collectively, the “Released Parties”) from all claims of any kind, known and unknown, that you had in the past or now have against the Released Parties through the date you sign this Bridge Release (except for claims arising out of the Separation Agreement and this Bridge Release). Without limitation, this full waiver and release includes all claims for compensation of any kind, and all claims arising from your employment with the Company, the termination of your employment, and/or the events leading up to the termination of your employment, and the terms of the Grant or its cancellation, whether based on contract, tort, statute, local ordinance, regulation or any comparable law in any jurisdiction (collectively, the “Released Claims”). By way of example and not in limitation, the Released Claims shall include any claims arising under Section 806 of the Sarbanes-Oxley Act of 2002 (“Civil Whistle Blower Provisions”), Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Older Workers Benefit and Protection Act, the Family and Medical Leave Act, the California Labor Code, the California Family Rights Act, and the California Fair Employment and Housing Act, as well as any claims asserting wrongful termination, discrimination, retaliation, harassment, breach of contract, breach of the covenant of good faith and fair dealing, all claims related to the return or recovery of any personal property allegedly remaining with or left at the Company, negligent or intentional infliction of emotional distress, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, and defamation, provided, however, that you are not releasing any claims to challenge the validity of this release under the Age Discrimination in Employment Act, any claims brought before the EDD, any claims that arise after you sign this Bridge Release, or any claims that you cannot waive by operation of law. Not withstanding the above, this Agreement is not waiving (a) claims relating to the validity of this Agreement; (b) claims which are not legally waiveable; (c) claims for coverage under any D&O or other similar insurance policy or (d) claims for indemnification under any statute or agreement with the Company.
|
2.
|
SECTION 1542 WAIVER.
You further agree that because this release specifically covers known and unknown claims, you waive your rights under Section 1542 of the California Civil Code, which states as follows:
|
3.
|
VOLUNTARY AND KNOWING RELEASE.
By your signature below, you acknowledge each of the following:
|
4.
|
ENTIRE AGREEMENT.
This Bridge Release and the Separation Agreement, constitute the complete, final and exclusive embodiment of the entire agreement between you and the Company with respect to the subject matter hereof. The Bridge Release is executed without reliance upon any promise, warranty or representation, written or oral, by any party or any
|
5.
|
APPLICABLE LAW.
This Bridge Release shall be deemed to have been entered into and shall be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California. Any action brought to enforce this Bridge Release, and any action arising out of, in connection with, or relating to this Bridge Release, shall be subject to the exclusive jurisdiction of the state and federal courts located in the Northern District of California. Both parties waive the right to a jury trial in any such action, and each party shall bear the costs and fees it incurs in any such action.
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Marvell Technology Group Ltd.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: June 5, 2017
|
By:
|
/s/ MATTHEW J. MURPHY
|
|
|
Matthew J. Murphy
President and Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Marvell Technology Group Ltd.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: June 5, 2017
|
By:
|
/s/ JEAN HU
|
|
|
Jean Hu
Chief Financial Officer
(Principal Financial Officer)
|
(i)
|
the Quarterly Report of the Registrant on Form 10-Q for the fiscal quarter ended
April 29, 2017
(the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(ii)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
Date: June 5, 2017
|
By:
|
/s/ MATTHEW J. MURPHY
|
|
|
Matthew J. Murphy
President and Chief Executive Officer
(Principal Executive Officer)
|
(i)
|
the Quarterly Report of the Registrant on Form 10-Q for the fiscal quarter ended
April 29, 2017
(the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(ii)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
Date: June 5, 2017
|
By:
|
/s/ JEAN HU
|
|
|
Jean Hu
Chief Financial Officer
(Principal Financial Officer)
|